Compounds > 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and pik 75

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with pik 75 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hayakawa, M; Kaizawa, H; Kawaguchi, K; Koizumi, T; Ohishi, T; Ohta, M; Okada, M; Parker, P; Raynaud, FI; Tsukamoto, S; Waterfield, MD; Workman, P; Yamano, M1
Bharate, SB; Raghuvanshi, R1

Other Studies

2 other study(ies) available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and pik 75

ArticleYear
Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110alpha inhibitors.
    Bioorganic & medicinal chemistry, 2007, Sep-01, Volume: 15, Issue:17

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Humans; Hydrazones; Imidazoles; Inhibitory Concentration 50; Isoenzymes; Mice; Molecular Structure; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Subunits; Pyridines; Structure-Activity Relationship; Sulfur; Temperature; Xenograft Model Antitumor Assays

2007
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases

2022